BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jacobs CF, Eldering E, Kater AP. Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19. Blood Adv 2021;5:913-25. [PMID: 33560402 DOI: 10.1182/bloodadvances.2020003768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Barcellini W, Fattizzo B. Immune Phenomena in Myeloid Neoplasms: An "Egg or Chicken" Question. Front Immunol 2021;12:751630. [PMID: 34659257 DOI: 10.3389/fimmu.2021.751630] [Reference Citation Analysis]
2 Morales-Ortega A, Farfán-Sedano AI, Izquierdo-Martínez A, Llarena-Barroso C, Jaenes-Barrios B, Mesa-Plaza N, Toledano-Macías M, Soria Fernández-Llamazares G, Molina-Esteban L, García de Tena J, Prieto-Menchero S, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients. J Infect 2021:S0163-4453(21)00436-9. [PMID: 34437930 DOI: 10.1016/j.jinf.2021.08.034] [Reference Citation Analysis]